help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Complementary and Alternative Therapies for Cancer
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassileth, B. R.
Right arrow Articles by Deng, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassileth, B. R.
Right arrow Articles by Deng, G.
The Oncologist, Vol. 9, No. 1, 80–89, February 2004
© 2004 AlphaMed Press


ORIGINAL PAPER
Symptom Management and Supportive Care

Complementary and Alternative Therapies for Cancer

Barrie R. Cassileth, Gary Deng

Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Correspondence: Barrie R. Cassileth, Ph.D., Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, H13, New York, New York 10021, USA. Telephone: 212-639-8629; Fax: 212-794-5851; e-mail: Cassileth{at}mskcc.org

Many cancer patients use therapies promoted as literal alternatives to conventional medical care. Such "alternative" modalities are unproven or were studied and found worthless. These can be harmful. An even greater proportion of cancer patients uses "complementary" therapies along with mainstream cancer treatment. Most are helpful adjunctive approaches that control symptoms and enhance quality of life. This review describes alternative as well as complementary therapies commonly used today by cancer patients. Herbal remedies also are discussed. Evidence regarding the efficacy and safety of complementary/alternative medicine (CAM) is reviewed, and implications for oncologists are discussed. To encourage open communication of CAM use by patients, oncologists should be knowledgeable about the most popular remedies and know where to find reliable information for themselves and for their patients.

Key Words. Cancer • Alternative medicine • Complementary therapies • Herbs • Dietary supplements




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
R. Ziegler and R. Grossarth-Maticek
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador)
Evid. Based Complement. Altern. Med., April 11, 2008; (2008) nen025v1.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. Hirai, K. Komura, A. Tokoro, T. Kuromaru, A. Ohshima, T. Ito, Y. Sumiyoshi, and I. Hyodo
Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients
Ann. Onc., January 1, 2008; 19(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
R. Ziegler
Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?
Evid. Based Complement. Altern. Med., October 4, 2007; (2007) nem121v1.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. R. Cassileth, G. E. Deng, J. E. Gomez, P. A. S. Johnstone, N. Kumar, and A. J. Vickers
Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 340S - 354S.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
S. Lev-ari, Y. Maimon, and N. Yaal-Hahoshen
Long-term Survival of a Patient With Widespread Metastases From Epithelial Ovarian Carcinoma Receiving Mind-Body Therapies: Case Report and Review of the Literature.
Integr Cancer Ther, December 1, 2006; 5(4): 395 - 399.
[Abstract] [PDF]


Home page
Evid Based Complement Alternat MedHome page
M. Carlsson, M. Arman, M. Backman, U. Flatters, T. Hatschek, and E. Hamrin
A Five-year Follow-up of Quality of Life in Women with Breast Cancer in Anthroposophic and Conventional Care
Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Animal Hospital AssociationHome page
S. E. Lana, L. R. Kogan, K. A. Crump, J. T. Graham, and N. G. Robinson
The use of complementary and alternative therapies in dogs and cats with cancer.
J. Am. Anim. Hosp. Assoc., September 1, 2006; 42(5): 361 - 365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. S. Svatek, J. J. Lee, C. G. Roehrborn, S. M. Lippman, and Y. Lotan
The cost of prostate cancer chemoprevention: a decision analysis model.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1485 - 1489.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen
Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence
Oncologist, July 1, 2006; 11(7): 732 - 741.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
Y. Cui, X.-O. Shu, Y.-T. Gao, H. Cai, M.-H. Tao, and W. Zheng
Association of Ginseng Use with Survival and Quality of Life among Breast Cancer Patients
Am. J. Epidemiol., April 1, 2006; 163(7): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. J. Padayatty, H. D. Riordan, S. M. Hewitt, A. Katz, L. J. Hoffer, and M. Levine
Intravenously administered vitamin C as cancer therapy: three cases.
Can. Med. Assoc. J., March 28, 2006; 174(7): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
K.-K. Hui, E. K. Hui, and M. F. Johnston
The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-west medicine.
Integr Cancer Ther, March 1, 2006; 5(1): 56 - 62.
[Abstract] [PDF]


Home page
Integr Cancer TherHome page
D. M. Hann, F. Baker, C. S. Roberts, C. Witt, J. McDonald, M. Livingston, J. Ruiterman, R. Ampela, C. Crammer, and O. Kaw
Use of Complementary Therapies Among Breast and Prostate Cancer Patients During Treatment: A Multisite Study
Integr Cancer Ther, December 1, 2005; 4(4): 294 - 300.
[Abstract] [PDF]


Home page
Integr Cancer TherHome page
D. Hann, F. Baker, M. Denniston, and N. Entrekin
Long-term Breast Cancer Survivors' Use of Complementary Therapies: Perceived Impact on Recovery and Prevention of Recurrence
Integr Cancer Ther, March 1, 2005; 4(1): 14 - 20.
[Abstract] [PDF]


Home page
ASH Education BookHome page
D. S. Rosenthal and E. Dean-Clower
Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies
Hematology, January 1, 2005; 2005(1): 491 - 497.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2004 by AlphaMed Press.